• • MANAGEMENT TEAM
  • BOARD OF DIRECTORS
  • SCIENTIFIC / CLINICAL ADVISORY BOARD
  • INVESTORS
• • PARP INHIBITOR PROGRAM
  • BSI-201: CLINICAL PARP INHIBITOR (IV)
  • BSI-401: PRECLINICAL PARP INHIBITOR (ORAL)
  • BSI-301: PRECLINICAL IODOTHYRONINE PROGRAM

click to enlarge
 

click to enlarge